Yusuf Acikgoz

6PUBLICATIONS
11CO-AUTHORS
Cancer cell biologyPredictive and prognostic markersNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 12, 2023
Advances in non-clear cell renal cell carcinoma management: From heterogeneous biology to treatment options.

Nathaniel R Wilson, Yusuf Acikgoz, Elshad Hasanov

|Oct 09, 2023
Treatment Outcomes and Prognostic Factors in N3 Stage Gastric Cancer After Curative Resection: A Real World Data.

Eda Caliskan Yildirim, Yusuf Acikgoz, Yakup Ergun

|Feb 19, 2021
Is there any clinical or laboratory predictive factor for cetuximab-induced skin toxicity?

Yusuf Acikgoz, Oznur Bal, Gokhan Ucar

|Jun 20, 2020
Is there any correlation among MKK4 (mitogen-activated protein kinase kinase 4) expression, clinicopathological features, and KRAS/NRAS mutation in colorectal cancer.

Mutlu Dogan, Servet Guresci, Yusuf Acikgoz

|Apr 18, 2020
The prognostic value of the prognostic nutritional index in patients with metastatic colorectal cancer.

Gokhan Ucar, Yakup Ergun, Yusuf Acikgoz

|Nov 14, 2019
KRAS codon 12 and 13 mutations may guide the selection of irinotecan or oxaliplatin in first-line treatment of metastatic colorectal cancer.

Yakup Ergun, Yusuf Acikgoz, Oznur Bal

Pageof 1

Frequent Collaborators

5 joint publications

Yakup Ergun

3 joint publications

Oznur Bal

3 joint publications

Gokhan Ucar

2 joint publications

Merve Dirikoc